Sanctuary Advisors
UTMD icon

Sanctuary Advisors’s Utah Medical Products UTMD Stock Holding History

Sanctuary Advisors’s Portfolio UTMD Stock Details UTMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$544K Buy
7,886
+4,258
+117% +$283K ﹤0.01% 1921
2026
Q1 		$225K Buy
+3,628
New +$229K ﹤0.01% 2288
2025
Q4 		– Sell
-3,706
Closed -$233K – 2576
2025
Q3 		$233K Sell
3,706
-794
-18% -$47K ﹤0.01% 2168
2025
Q2 		$256K Sell
4,500
-3,060
-40% -$166K ﹤0.01% 2010
2025
Q1 		$424K Buy
7,560
+599
+9% +$35.9K ﹤0.01% 1612
2024
Q4 		$426K Buy
6,961
+963
+16% +$62.3K ﹤0.01% 1788
2024
Q3 		$392K Sell
5,998
-268
-4% -$18.2K ﹤0.01% 1849
2024
Q2 		$413K Buy
+6,266
New +$427K ﹤0.01% 1761

Other funds holding UTMD

Brandes Investment Partners
Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
MA
Minerva Advisors Bala Cynwyd, Pennsylvania $158M AUM 42.05% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return
Rice Hall James & Associates
Rice Hall James & Associates San Diego, California $2.05B AUM 43.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sanctuary Advisors's UTMD Position: Q2 2026 in Review

Sanctuary Advisors increased its Utah Medical Products (UTMD) stake by 117% in Q2 2026, buying an estimated $283K and bringing the position to 7,886 shares worth $544K. The position accounts for ﹤0.01% of the portfolio, ranked #1921.

Sanctuary Advisors first reported a position in UTMD in Q2 2024 and has held it in 8 quarters since. 114 funds tracked by Wall St. Rank hold UTMD as of Q2 2026.

  • Sanctuary Advisors held 7,886 shares of Utah Medical Products worth $544K as of Q2 2026.
  • Sanctuary Advisors bought 4,258 Utah Medical Products shares in Q2 2026, an estimated $283K.
  • Utah Medical Products made up ﹤0.01% of Sanctuary Advisors's portfolio in Q2 2026, its #1921 holding.
  • Sanctuary Advisors first reported a position in Utah Medical Products in Q2 2024 and has held it in 8 quarters since.
  • 114 funds tracked by Wall St. Rank held Utah Medical Products as of Q2 2026.

Based on Sanctuary Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.